1-[2-(5-methyl-1H-indol-3-yl)ethyl]-5-oxopyrrolidine-3-carboxylic acid
- $378 - $770
- Product name: 1-[2-(5-methyl-1H-indol-3-yl)ethyl]-5-oxopyrrolidine-3-carboxylic acid
- CAS: 931374-78-6
- MF: C16H18N2O3
- MW: 286.33
- EINECS:
- MDL Number:MFCD09271356
- Synonyms:1-[2-(5-methyl-1H-indol-3-yl)ethyl]-5-oxopyrrolidine-3-carboxylic acid;3-pyrrolidinecarboxylic acid, 1-[2-(5-methyl-1H-indol-3-yl)ethyl]-5-oxo-;3-pyrrolidinecarboxylic acid, 1-[2-(5-methyl-1H-indol-3-yl
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
Package
- 0.5G
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0083213
- Product description1-[2-(5-METHYL-1H-INDOL-3-YL)ETHYL]-5-OXOPYRROLIDINE-3-CARBOXYLIC ACID 95.00%
- Packaging0.5G
- Price$770
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM261569
- Product description1-(2-(5-Methyl-1H-indol-3-yl)ethyl)-5-oxopyrrolidine-3-carboxylicacid 95%+
- Packaging1g
- Price$378
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD21000699
- Product description1-(2-(5-Methyl-1H-indol-3-yl)ethyl)-5-oxopyrrolidine-3-carboxylicacid 97%
- Packaging1g
- Price$400
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0083213 | 1-[2-(5-METHYL-1H-INDOL-3-YL)ETHYL]-5-OXOPYRROLIDINE-3-CARBOXYLIC ACID 95.00% | 0.5G | $770 | 2021-12-16 | Buy |
Chemenu | CM261569 | 1-(2-(5-Methyl-1H-indol-3-yl)ethyl)-5-oxopyrrolidine-3-carboxylicacid 95%+ | 1g | $378 | 2021-12-16 | Buy |
Crysdot | CD21000699 | 1-(2-(5-Methyl-1H-indol-3-yl)ethyl)-5-oxopyrrolidine-3-carboxylicacid 97% | 1g | $400 | 2021-12-16 | Buy |
Properties
Boiling point :598.8±50.0 °C(Predicted)
Density :1.328±0.06 g/cm3(Predicted)
pka :4.53±0.20(Predicted)
Density :1.328±0.06 g/cm3(Predicted)
pka :4.53±0.20(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|